Samia al - Faqi
Dr. Nur Al-Haraki, Psychiatric Consultant and behavioural modification, confirmed that the common link between depression and the mere existence of chemical disorder or a shortage of serotonin carrier is a reduction of highly complex disease, explaining that serotonin is already playing a key role in the regulation of mood, sleep, appetite and energy, and that the disorder of his system is linked to individual symptoms, but the disease actually arises as a result of a complex intersect between biological agents.
The mover pointed out that the symptoms of depression go beyond cross-grief to include continued grief, loss of passion for fun activities, sleep disorders, exhaustion and energy shortages, as well as difficulty of concentration and decision-making, permanent guilt and lack of value. In therapeutic context.
Dr. Noor pointed out that sertraline medications are increasing the availability of this neurotransmitter between cells, effectively helping patients to improve moods and gradually reduce their anxiety and depression, emphasizing that early remedial intervention, psychological support and continuous follow-up with specialists are the basic pillars of recovery and quality of life.
It should be noted that regional and international estimates and surveys indicate that the prevalence of depression symptoms in the Arab world ranges from 25 per cent to 30 per cent on average among the adult population, which is more than the estimated global average of about 5% according to the World Health Organization (WHO), owing mainly to political unrest, armed conflicts and successive economic crises in the region.
